News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
356,617 Results
Type
Article (21549)
Company Profile (141)
Press Release (334922)
Multimedia
Podcasts (105)
Webinars (17)
Section
Business (109086)
Career Advice (894)
Deals (19541)
Drug Delivery (104)
Drug Development (52200)
Employer Resources (80)
FDA (8171)
Job Trends (8083)
News (192788)
Policy (18040)
Tag
Academia (746)
Accelerated approval (13)
Adcomms (22)
Allergies (74)
Alliances (28796)
ALS (80)
Alzheimer's disease (775)
Antibody-drug conjugate (ADC) (181)
Approvals (8304)
Artificial intelligence (251)
Autoimmune disease (59)
Automation (12)
Bankruptcy (179)
Best Places to Work (5718)
BIOSECURE Act (14)
Biosimilars (151)
Biotechnology (59)
Bladder cancer (70)
Brain cancer (30)
Breast cancer (216)
Cancer (2069)
Cardiovascular disease (224)
Career advice (739)
Career pathing (23)
CAR-T (90)
CDC (14)
Cell therapy (255)
Cervical cancer (10)
Clinical research (45394)
Collaboration (863)
Company closure (1)
Compensation (332)
Complete response letters (46)
COVID-19 (1155)
CRISPR (45)
C-suite (448)
Cystic fibrosis (83)
Data (2922)
Decentralized trials (2)
Denatured (26)
Depression (70)
Diabetes (243)
Diagnostics (1970)
Digital health (14)
Diversity (8)
Diversity, equity & inclusion (22)
Drug discovery (148)
Drug pricing (180)
Drug shortages (33)
Duchenne muscular dystrophy (122)
Earnings (42287)
Editorial (42)
Employer branding (10)
Employer resources (78)
Events (52125)
Executive appointments (618)
FDA (9574)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (3)
Frontotemporal dementia (4)
Funding (589)
Gene editing (82)
Generative AI (26)
Gene therapy (241)
GLP-1 (773)
Government (2016)
Grass and pollen (4)
Guidances (206)
Healthcare (6099)
HIV (30)
Huntington's disease (20)
IgA nephropathy (55)
Immunology and inflammation (152)
Immuno-oncology (18)
Indications (46)
Infectious disease (1279)
Inflammatory bowel disease (109)
Inflation Reduction Act (11)
Influenza (40)
Intellectual property (119)
Interviews (118)
IPO (7751)
IRA (52)
Job creations (2555)
Job search strategy (657)
Kidney cancer (10)
Labor market (58)
Layoffs (340)
Leadership (26)
Legal (4367)
Liver cancer (37)
Longevity (7)
Lung cancer (317)
Lymphoma (178)
Machine learning (18)
Management (31)
Manufacturing (450)
MASH (97)
Medical device (2323)
Medtech (2329)
Mergers & acquisitions (12276)
Metabolic disorders (799)
Multiple sclerosis (87)
NASH (20)
Neurodegenerative disease (138)
Neuropsychiatric disorders (53)
Neuroscience (1409)
NextGen: Class of 2025 (2386)
Non-profit (924)
Now hiring (42)
Obesity (449)
Opinion (224)
Ovarian cancer (59)
Pain (123)
Pancreatic cancer (81)
Parkinson's disease (140)
Partnered (16)
Patents (257)
Patient recruitment (181)
Peanut (20)
People (35181)
Pharmaceutical (76)
Pharmacy benefit managers (30)
Phase I (14192)
Phase II (19112)
Phase III (15448)
Pipeline (2068)
Policy (217)
Postmarket research (1736)
Preclinical (4987)
Press Release (29)
Prostate cancer (123)
Psychedelics (24)
Radiopharmaceuticals (175)
Rare diseases (428)
Real estate (3266)
Recruiting (33)
Regulatory (13823)
Reports (28)
Research institute (846)
Resumes & cover letters (140)
Rett syndrome (3)
RNA editing (9)
RSV (43)
Schizophrenia (108)
Series A (103)
Series B (71)
Service/supplier (7)
Sickle cell disease (55)
Special edition (21)
Spinal muscular atrophy (115)
Sponsored (17)
Startups (2079)
State (2)
Stomach cancer (11)
Supply chain (70)
Tariffs (91)
The Weekly (77)
Vaccines (387)
Venture capital (55)
Weight loss (332)
Women's health (31)
Worklife (8)
Date
Last 7 days (299)
Last 30 days (1249)
Last 365 days (15873)
2025 (15054)
2024 (18094)
2023 (20193)
2022 (27106)
2021 (28080)
2020 (26122)
2019 (20693)
2018 (15947)
2017 (17922)
2016 (16768)
2015 (19590)
2014 (15428)
2013 (13025)
2012 (14028)
2011 (14295)
2010 (13191)
Location
Africa (421)
Alabama (36)
Alaska (1)
Arizona (87)
Arkansas (8)
Asia (25929)
Australia (3342)
California (4415)
Canada (1703)
China (631)
Colorado (176)
Connecticut (179)
Delaware (161)
Europe (60607)
Florida (766)
Georgia (92)
Hawaii (1)
Idaho (18)
Illinois (402)
India (45)
Indiana (269)
Iowa (4)
Japan (264)
Kansas (82)
Kentucky (28)
Louisiana (5)
Maine (4)
Maryland (584)
Massachusetts (3637)
Michigan (62)
Minnesota (223)
Mississippi (3)
Missouri (40)
Montana (12)
Nebraska (13)
Nevada (37)
New Hampshire (8)
New Jersey (1734)
New Mexico (21)
New York (1231)
North Carolina (736)
North Dakota (2)
Northern California (2003)
Ohio (118)
Oklahoma (8)
Oregon (23)
Pennsylvania (1028)
Puerto Rico (17)
Rhode Island (24)
South America (626)
South Carolina (10)
Southern California (1885)
Tennessee (61)
Texas (588)
United States (16990)
Utah (89)
Virginia (162)
Washington D.C. (57)
Washington State (358)
West Virginia (1)
Wisconsin (40)
Wyoming (1)
356,617 Results for "midatech pharma plc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Midatech Pharma PLC Announces Results of General Meeting
Midatech Pharma PLC is pleased to announce that at the general meeting of the Company held earlier today all resolutions put to the Company’s shareholders were duly passed.
March 24, 2023
·
6 min read
Midatech Pharma PLC Announces R&D Programme Focused on Leptomeningeal Disease
Midatech Pharma PLC is pleased to announce a new research programme coded MTD217 focusing on developing new therapeutic options for metastatic cancers with high unmet needs.
March 27, 2023
·
6 min read
Drug pricing
UK Agrees To Boost Drug Spending by 25% To Avoid US Pharma Tariffs
U.K.-based pharmas will not face tariffs as long as Donald Trump is president, according to the agreement.
December 1, 2025
·
1 min read
·
Annalee Armstrong
Pharm Country
Bioasis Technologies Inc. Announces Termination of Arrangement Agreement with Midatech Pharma plc
BIOASIS TECHNOLOGIES INC today announced that it has terminated the arrangement agreement (the “Arrangement Agreement”) dated December 13, 2022, as amended December 18, 2022, between Bioasis and Midatech Pharma plc (“Midatech”).
January 23, 2023
·
4 min read
Midatech Pharma PLC Announces Result of General Meeting
Midatech Pharma PLC announces that at its General Meeting held at 10.00 a.m. today all ordinary resolutions were carried, but all other resolutions were not passed by shareholders, as set out in the table below.
January 23, 2023
·
7 min read
Editorial
GSK CEO Emma Walmsley’s Departure Reseals Pharma’s Glass Ceiling
After Emma Walmsley steps down as GSK CEO in January, Vertex Pharma’s Reshma Kewalramani will be the sole female CEO at a top-20 pharma company. Still, there are many prominent women in pharma that could someday break through again.
September 29, 2025
·
1 min read
·
Annalee Armstrong
Mergers & acquisitions
Five Assets Given Away by Big Pharma That Ultimately Got Bought for Billions
Drug candidates don’t usually move among Big Pharma, but these five biotechs helped facilitate such hand-offs, scooping up assets from one pharma on the cheap before being bought out for billions by another.
November 19, 2025
·
9 min read
·
Tristan Manalac
Midatech Pharma PLC Announces Posting of Circular and Notice of General Meeting
Midatech Pharma PLC announces, further to the Company’s announcements of 13 December and 19 December 2022, that a circular and Notice of General Meeting was posted to shareholders yesterday.
January 6, 2023
·
7 min read
Business
Bioasis Technologies Inc. Announces Amendments to Arrangement Agreement with Midatech Pharma plc
BIOASIS TECHNOLOGIES INC. today announced the following amendments to the terms of the previously announcement arrangement agreement with Midatech Pharma plc.
December 19, 2022
·
4 min read
Mergers & acquisitions
5 SMID-Cap Pharmas Poised for M&A Action
Mergers and acquisitions are not just for Big Pharma. A new report from Leerink Partners takes a stab at identifying the small- to mid-cap pharmas best prepared to bolster their pipelines with a buyout.
October 29, 2025
·
7 min read
·
Annalee Armstrong
1 of 35,662
Next
